Hayman TJ - Search Results

1

The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.

Kahn J, Hayman TJ, Jamal M, Rath BH, Kramp T, Camphausen K, Tofilon PJ. Kahn J, et al. Among authors: hayman tj. Neuro Oncol. 2014 Jan;16(1):29-37. doi: 10.1093/neuonc/not139. Epub 2013 Dec 4. Neuro Oncol. 2014. PMID: 24311635 Free PMC article.

2

Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell Radiosensitivity.

Hayman TJ, Kramp T, Kahn J, Jamal M, Camphausen K, Tofilon PJ. Hayman TJ, et al. Transl Oncol. 2013 Jun 1;6(3):355-62. doi: 10.1593/tlo.13163. Print 2013 Jun. Transl Oncol. 2013. PMID: 23730416 Free PMC article.

3

The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cells.

Hayman TJ, Wahba A, Rath BH, Bae H, Kramp T, Shankavaram UT, Camphausen K, Tofilon PJ. Hayman TJ, et al. Clin Cancer Res. 2014 Jan 1;20(1):110-9. doi: 10.1158/1078-0432.CCR-13-2136. Epub 2013 Nov 6. Clin Cancer Res. 2014. PMID: 24198241 Free PMC article.

4

Translation initiation factor eIF4E is a target for tumor cell radiosensitization.

Hayman TJ, Williams ES, Jamal M, Shankavaram UT, Camphausen K, Tofilon PJ. Hayman TJ, et al. Cancer Res. 2012 May 1;72(9):2362-72. doi: 10.1158/0008-5472.CAN-12-0329. Epub 2012 Mar 7. Cancer Res. 2012. PMID: 22397984 Free PMC article.

5

Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer.

Chuong MD, Hayman TJ, Patel MR, Russell MS, Malafa MP, Hodul PJ, Springett GM, Choi J, Shridhar R, Hoffe SE. Chuong MD, et al. Among authors: hayman tj. Gastrointest Cancer Res. 2011 Jul;4(4):128-34. Gastrointest Cancer Res. 2011. PMID: 22368736 Free PMC article.

6

Outcomes of resected pancreatic cancer in patients age ≥70.

Hayman TJ, Strom T, Springett GM, Balducci L, Hoffe SE, Meredith KL, Hodul P, Malafa M, Shridhar R. Hayman TJ, et al. J Gastrointest Oncol. 2015 Oct;6(5):498-504. doi: 10.3978/j.issn.2078-6891.2015.038. J Gastrointest Oncol. 2015. PMID: 26487943 Free PMC article.

7

Body mass index and survival in esophageal adenocarcinoma treated with chemoradiotherapy followed by esophagectomy.

Shridhar R, Hayman T, Hoffe SE, Weber J, Almhanna K, Chuong M, Karl RC, Meredith KL. Shridhar R, et al. J Gastrointest Surg. 2012 Jul;16(7):1296-302. doi: 10.1007/s11605-012-1843-4. Epub 2012 Mar 8. J Gastrointest Surg. 2012. PMID: 22399271

8

Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review.

Hayman TJ, Bhatia AK, Jethwa KR, Young MR, Park HS. Hayman TJ, et al. Transl Cancer Res. 2021 May;10(5):2571-2585. doi: 10.21037/tcr-20-2096. Transl Cancer Res. 2021. PMID: 35116571 Free PMC article. Review.

9

CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma.

Chen WS, Bindra RS, Mo A, Hayman T, Husain Z, Contessa JN, Gaffney SG, Townsend JP, Yu JB. Chen WS, et al. Front Oncol. 2018 Apr 4;8:95. doi: 10.3389/fonc.2018.00095. eCollection 2018. Front Oncol. 2018. PMID: 29670856 Free PMC article.

10

STING Agonists in Head and Neck Squamous Cell Carcinoma.

Wallington DG, Contessa JN, Hayman TJ. Wallington DG, et al. Among authors: hayman tj. Cancer J. 2022 Sep-Oct 01;28(5):401-406. doi: 10.1097/PPO.0000000000000620. Cancer J. 2022. PMID: 36165729 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters